Microcirculatory effects of fluid therapy and dopamine, associated or not to fluid therapy, in endotoxemic hamsters

Clinical Hemorheology and Microcirculation

Volumn 47, Issue 1, 2011, Pages 1-13

  Santos, Ana Olimpia M T ^a   Furtado, Eliane S ^a   Villela, Nivaldo R ^a   Bouskela, Eliete ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

arteriolar diameter; dorsal window chamber preparation; functional capillary density; Lipopolysaccharide; microvascular reactivity; venular diameter

Indexed keywords

DOPAMINE; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; FLUID RESUSCITATION; FLUID THERAPY; FUNCTIONAL CAPILLARY DENSITY; HAMSTER; MALE; MICROCIRCULATION; NONHUMAN; SCORING SYSTEM; SURVIVAL TIME; TISSUE PERFUSION;

ANIMALS; CAPILLARIES; CRICETINAE; DOPAMINE; ENDOTOXEMIA; ESCHERICHIA COLI INFECTIONS; FLUID THERAPY; HEART RATE; LIPOPOLYSACCHARIDES; MALE; MICROCIRCULATION; RANDOM ALLOCATION; RESUSCITATION; SHOCK, SEPTIC;

EID: 79951837349     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1358     Document Type: Article

References (48)

1. M.E. Astiz, G.E. DeGent, R.Y. Lin, et al., Microvascular function and rheologic changes in hyperdynamic sepsis, Crit Care Med 23 (1995), 265-271.
2. R. Bellomo, M. Chapman, S. Finfer, et al., Low-dose dopamine in patients with early renal dysfunction: A placebocontrolled randomised trial, Australian and New Zealand Intensive Care Society (ANZICS) clinical trials group, Lancet 356 (2000), 2139-2143.
3. E. Bouskela and G.M. Rubanyi, Effects ofNW-nitro-L-arginine and dexamethasone on early events following lipopolysaccharide injection: Observations in the hamster cheek pouch microcirculation, Shock 1 (1994), 347-353.
4. P. Cabrales, A.G. Tsai and M. Intaglietta, Is resuscitation from hemorrhagic shock limited by blood oxygen (Pubitemid 46594969)
5. J.A. Carcillo, A.L. Davis and A. Zaritsky, Role of early fluid resuscitation in pediatric septic shock, JAMA 266 (1991), 1242-1245.
6. G.C. Carroll and J.V. Snyder, Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey, Am J Physiol 243 (1982), R131-R141. (Pubitemid 12092171)
7. M. Chierego, C. Verdant and D. De Backer, Microcirculatory alterations in critically ill patients, Minerva Anestesiol 72 (2006), 199-205.
8. R.S. Croner, E. Hoerer, Y. Kulu, et al., Hepatic platelet and leukocyte adherence during endotoxemia, Crit Care 10 (2006), R15.
9. D. De Backer, J. Creteur, J.C. Preiser, et al., Microvascular blood flow is altered in patients with sepsis, Am J Respir Crit Care Med 166 (2002), 98-104. (Pubitemid 34693970)
10. D. De Backer, J. Creteur, M.J. Dubois, et al., The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects, Crit Care Med 34 (2006), 403-408. (Pubitemid 43145619)
11. D. De Backer, P. Biston, J. Devriendt, et al., Comparison of dopamine and norepinephrine in the treatment of shock, N Engl J Med 362 (2010), 779-789.
12. R.P. Dellinger, M.M. Levy, J.M. Carlet, et al., Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, Crit Care Med 36 (2008), 296-327.
13. V. D'Orio, D. el Allaf, J. Juchmes, et al., The use of low doses of dopamine in intensive care medicine, Arch Int Physiol Biochim 92 (1984), S11-S20.
14. E.M. Drost, G. Kassabian, H.J. Meiselman, et al., Increased rigidity and priming of polymorphonuclear leukocytes in sepsis, Am J Respir Crit Care Med 159 (1999), 1696-1702. (Pubitemid 29275030)
15. A. Dubin, M.O. Pozo, G. Ferrara, et al., Systemic and microcirculatory responses to progressive hemorrhage, Intensive Care Med 35 (2009), 556-564.
16. C.G. Ellis, R.M. Bateman, M.D. Sharpe, et al., Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis, Am J Physiol Heart Circ Physiol 282 (2002), H156-H164. (Pubitemid 34654146)
17. S. Ghosh, R.D. Latimer, B.M. Gray, et al., Endotoxin-induced organ injury, Crit Care Med 2(Suppl.) (1993), S19-S24. (Pubitemid 23057709)
18. G.D. Giraud and K.L. MacCannell, Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation, J Pharmacol Exp Ther 230 (1984), 214-220. (Pubitemid 14097680)
19. I.L. Gordon, R. Wesley, D.H. Wong, et al., Effect of dopamine on renal blood flow and cardiac output, Arch Surg 130 (1995), 864-868.
20. L.B. Hiltebrand, V. Krejci and G.H. Sigurdsson, Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia, Anesthesiology 100 (2004), 1188-1197. (Pubitemid 38541975)
21. J.N. Hoffmann, B.Vollmar,D. Inthorn, et al.,Achronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia, Shock 12 (1999), 355-364.
22. C.L. Holmes and K.R. Walley, Bad medicine: Low-dose dopamine in the ICU, Chest 123 (2003), 1266-1275. (Pubitemid 36444387)
23. S. Keller, A. Karaa, M. Paxian, et al., Inhibition of endothelin-1-mediated up-regulation of iNOS by bosentan ameliorates endotoxin-induced liver injury in cirrhosis, Shock 25 (2006), 306-313.
24. H. Kerger, D.J. Saltzman, M.D. Menger, et al., Systemic and subcutaneous microvascular Po2 dissociation during 4-h hemorrhagic shock in conscious hamsters, Am J Physiol 270 (1996), H827-H836.
25. M.R. Marchick, J.A. Kline and A.E. Jones, The significance of non-sustained hypotension in emergency department patients with sepsis, Intensive Care Med 35 (2009), 1261-1264.
26. P.E. Marik and M. Mohedin, The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis, JAMA 272 (1994), 1354-1357. (Pubitemid 24323617)
27. G.S. Martin, D.M. Mannino, S. Eaton, et al., The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med 348 (2003), 1546-1554. (Pubitemid 36437931)
28. D. Nolte, H. Zeintl, M. Steinbauer, et al., Functional capillary density: An indicator of tissue perfusion? Int J Microcirc Clin Exp 15 (1995), 244-249.
29. N.V. Olsen, M.H. Olsen, J. Bonde, et al., Dopamine natriuresis in salt-repleted, water-loaded humans: A dose-response study, Br J Clin Pharmacol 43 (1997), 509-520. (Pubitemid 27224011)
30. D. Olson, A. Pohlman and J.B. Hall, Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance,AmJ Respir Crit Care Med 154 (1996), 1664-1670. (Pubitemid 26424932)
31. J.E. Parrillo, M.M. Parker, C. Natanson, et al., Septic shock in humans, Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy, Ann Intern Med 113 (1990), 227-242. (Pubitemid 20242299)
32. O. Piazza, G. Zito, A. Valente, et al., Effects of dopamine infusion on forearm blood flow in critical patients, Med Sci Monit 12 (2006), CR90-CR93. (Pubitemid 43200950)
33. P.R. Povoa, A.H. Carneiro, O.S. Ribeiro, et al., Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study), Crit Care Med 37 (2009), 410-416.
34. D.G. Remick, D.E. Newcomb, G.L. Bolgos, et al., Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide vs. cecal ligation and puncture, Shock 13 (2000), 110-116.
35. E. Rivers, B. Nguyen, S. Havstad, et al., Early goal-directed therapy in the treatment of severe sepsis and septic shock, N Engl J Med 345 (2001), 1368-1377.
36. E.P. Rivers, V. Coba, A. Visbal, et al., Management of sepsis: Early resuscitation, Clin Chest Med 29 (2008), 689-704, ix-x.
37. Y. Sakr, K. Reinhart, J.L. Vincent, et al., Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely Ill patients (SOAP) study, Crit Care Med 34 (2006), 589-597.
38. Y. Sakr, M.J. Dubois, D. De Backer, et al., Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock, Crit Care Med 32 (2004), 1825-1831. (Pubitemid 39202356)
39. J. Schneider, Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase, Thromb Res 72 (1993), 71-82. (Pubitemid 23293759)
40. L.A. Schwarte, O. Picker, A.W. Schindler, et al., Dopamine under alpha1-blockade, but not dopamine alone or fenoldopam, increases depressed gastric mucosal oxygenation, Crit Care Med 32 (2004), 150-156. (Pubitemid 38128350)
41. J.M. Segal, P.T. Phang and K.R. Walley, Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock, J Appl Physiol 73 (1992), 1159-1164.
42. P.E. Spronk, C. Ince, M.J. Gardien, et al., Nitroglycerin in septic shock after intravascular volume resuscitation, Lancet 360 (2002), 1395-1396. (Pubitemid 35341307)
43. S. Trzeciak and V. Rivers, Clinical manifestations of disordered microcirculatory perfusion in severe sepsis, Crit Care 4(Suppl.) (2005), S20-S26. (Pubitemid 41498528)
44. S. Trzeciak, I. Cinel, R.P. Dellinger, et al., Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials, Acad Emerg Med 15 (2008), 399-413.
45. S. Trzeciak, R.P. Dellinger, J.E. Parrillo, et al., Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival, Ann Emerg Med 49 (2007), 88-98, -e81-e82.
46. N.R. Villela, P. Cabrales, A.G. Tsai, et al., Microcirculatory effects of changing blood hemoglobin oxygen affinity during hemorrhagic shock resuscitation in an experimental model, Shock 31 (2009), 645-652.
47. J.L. Vincent and D. De Backer, Microvascular dysfunction as a cause of organ dysfunction in severe sepsis, Crit Care 4(Suppl.) (2005), S9-S12. (Pubitemid 41498526)
48. J.L. Vincent, P. Biston, J. Devriendt, et al., Dopamine versus norepinephrine: Is one better? Minerva Anestesiol 75 (2009), 333-337.